membre depuis:
Portefeuille démarré:
Dernière connexion:
10-10-17
12-10-17
05-05-26 10:53
Positions en cours
| Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 24/02/25 | OSE IMMUNOTHERAPEUTICS | Achat | 500 E | 6.93 | 3.70 | -46.82% | -234 |
|
0 |
| 17/12/24 | COGELEC SA | Achat | 500 E | 15.50 | 29.20 | 88.10% | 441 |
|
0 |
| 06/11/24 | MEDINCELL SA | Achat | 400 E | 15.22 | 25.78 | 69.11% | 276 |
|
0 |
| 28/10/24 | VALBIOTIS | Achat | 400 E | 1.27 | 1.11 | -12.47% | -50 |
|
0 |
| 28/10/24 | VALBIOTIS | Achat | 400 E | 1.34 | 1.11 | -17.05% | -68 |
|
0 |
| 22/10/24 | ADOCIA | Achat | 400 E | 8.51 | 4.11 | -51.90% | -208 |
|
0 |
| 21/10/24 | ADOCIA | Achat | 400 E | 7.65 | 4.11 | -46.48% | -186 |
|
0 |
| 02/10/24 | ADVICENNE | Achat | 500 E | 2.25 | 1.20 | -46.82% | -234 |
|
0 |
| 02/10/24 | ADVICENNE | Achat | 400 E | 2.29 | 1.20 | -47.75% | -191 |
|
0 |
| 01/10/24 | ADVICENNE | Achat | 400 E | 1.62 | 1.20 | -26.10% | -104 |
|
0 |
| 30/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 8.11 | 3.70 | -54.57% | -218 |
|
0 |
| 23/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 7.41 | 3.70 | -50.27% | -151 |
|
0 |
| 19/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 7.76 | 3.70 | -52.52% | -210 |
|
0 |
| 17/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 7.24 | 3.70 | -49.10% | -196 |
|
0 |
| 22/08/24 | VALBIOTIS | Achat | 400 E | 1.79 | 1.11 | -37.93% | -152 |
|
0 |
| 05/06/24 | VALBIOTIS | Achat | 400 E | 2.31 | 1.11 | -51.92% | -208 |
|
0 |
| 29/05/24 | ADVICENNE | Achat | 400 E | 2.47 | 1.20 | -51.57% | -206 |
|
0 |
| 29/05/24 | ADVICENNE | Achat | 400 E | 2.54 | 1.20 | -52.90% | -212 |
|
24 |
| 10/05/24 | MEDINCELL SA | Achat | 400 E | 14.96 | 25.78 | 72.05% | 288 |
|
0 |
| 10/05/24 | MEDINCELL SA | Achat | 400 E | 15.10 | 25.78 | 70.46% | 282 |
|
0 |
| 08/04/24 | ADOCIA | Achat | 400 E | 10.38 | 4.11 | -60.58% | -242 |
|
0 |
| 25/03/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 4.57 | 3.70 | -19.31% | -77 |
|
0 |
| 21/03/24 | REWORLD MEDIA | Achat | 400 E | 3.21 | 1.62 | -49.68% | -199 |
|
0 |
| 18/12/23 | INNATE PHARMA | Achat | 400 E | 2.34 | 1.54 | -34.35% | -137 |
|
0 |
| 08/11/23 | VALBIOTIS | Achat | 400 E | 6.46 | 1.11 | -82.87% | -331 |
|
0 |
| 19/09/23 | ADVICENNE | Achat | 500 E | 2.39 | 1.20 | -49.94% | -250 |
|
0 |
| 18/09/23 | ADVICENNE | Achat | 400 E | 2.42 | 1.20 | -50.56% | -202 |
|
0 |
| 14/06/23 | VALBIOTIS | Achat | 400 E | 4.32 | 1.11 | -74.34% | -297 |
|
0 |
| 13/06/23 | INNATE PHARMA | Achat | 400 E | 3.20 | 1.54 | -52.02% | -208 |
|
0 |
| 23/09/21 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 11.16 | 3.70 | -67.01% | -268 |
|
7 |
| 23/09/21 | INNATE PHARMA | Achat | 400 E | 6.15 | 1.54 | -75.08% | -300 |
|
7 |
| 21/09/21 | INNATE PHARMA | Achat | 400 E | 5.92 | 1.54 | -74.11% | -296 |
|
7 |
| 15/04/21 | VALBIOTIS | Achat | 400 E | 7.92 | 1.11 | -86.05% | -344 |
|
7 |
| 14/04/21 | VALBIOTIS | Achat | 400 E | 8.19 | 1.11 | -86.51% | -346 |
|
5 |
| 31/03/21 | ADVICENNE | Achat | 400 E | 12.00 | 1.20 | -90.11% | -360 |
|
7 |
| 16/03/21 | VALBIOTIS | Achat | 400 E | 7.84 | 1.11 | -85.91% | -344 |
|
7 |
| 10/02/21 | VALBIOTIS | Achat | 300 E | 7.56 | 1.11 | -85.38% | -256 |
|
7 |
| 04/02/21 | VALBIOTIS | Achat | 300 E | 6.98 | 1.11 | -84.16% | -252 |
|
4 |
| 21/01/21 | VALBIOTIS | Achat | 300 E | 6.78 | 1.11 | -83.69% | -251 |
|
8 |
| 27/11/20 | INNATE PHARMA | Achat | 300 E | 4.47 | 1.54 | -65.68% | -197 |
|
8 |
| 12/11/20 | INNATE PHARMA | Achat | 300 E | 3.82 | 1.54 | -59.83% | -179 |
|
7 |
| 11/11/20 | INNATE PHARMA | Achat | 300 E | 3.85 | 1.54 | -60.14% | -180 |
|
4 |
| 10/09/20 | INNATE PHARMA | Achat | 300 E | 3.39 | 1.54 | -54.72% | -164 |
|
7 |
| 09/09/20 | INNATE PHARMA | Achat | 300 E | 3.68 | 1.54 | -58.29% | -175 |
|
5 |
| 25/05/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 5.80 | 3.70 | -36.44% | -109 |
|
8 |
| 30/04/20 | ADVICENNE | Achat | 300 E | 8.82 | 1.20 | -86.51% | -260 |
|
6 |
| 24/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 5.02 | 3.70 | -26.55% | -80 |
|
7 |
| 23/04/20 | INNATE PHARMA | Achat | 300 E | 6.33 | 1.54 | -75.80% | -227 |
|
7 |
| 21/04/20 | INNATE PHARMA | Achat | 300 E | 6.39 | 1.54 | -76.02% | -228 |
|
7 |
| 20/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.38 | 3.70 | -15.80% | -47 |
|
6 |
| Enregistrements 1 à 50 sur 54 | |||||||||
Positions soldées
| Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 18/05/23 | GENSIGHT BIOLOGICS SA | Achat | 400 E | 3.34 | 0.89 | -73.48% | -294 | |
2 |
| 18/05/23 | GENSIGHT BIOLOGICS SA | Achat | 500 E | 0.74 | 0.89 | 20.05% | 100 | |
0 |
| 16/05/23 | TXCOM | Achat | 300 E | 8.15 | 8.80 | 7.77% | 23 | |
8 |
| 16/05/23 | TXCOM | Achat | 400 E | 8.60 | 8.80 | 2.12% | 8 | |
7 |
| 12/05/23 | TXCOM | Achat | 400 E | 8.60 | 8.75 | 1.54% | 6 | |
8 |
| 12/05/23 | TXCOM | Achat | 400 E | 8.40 | 8.75 | 3.96% | 16 | |
8 |
| 12/05/23 | EUROFINS SCIENTIFIC SE | Achat | 400 E | 86.95 | 60.76 | -30.29% | -121 | |
7 |
| 12/05/23 | EUROFINS SCIENTIFIC SE | Achat | 400 E | 86.19 | 60.76 | -29.68% | -119 | |
7 |
| 11/05/23 | GENSIGHT BIOLOGICS SA | Achat | 400 E | 4.21 | 1.08 | -74.47% | -298 | |
3 |
| 10/05/23 | GENSIGHT BIOLOGICS SA | Achat | 400 E | 4.05 | 0.82 | -79.87% | -319 | |
9 |
| 04/05/23 | VILMORIN & CIE | Achat | 2 000 E | 44.00 | 62.60 | 41.33% | 827 | |
0 |
| 15/03/23 | MANITOU GROUP | Achat | 2 000 E | 26.55 | 22.35 | -16.33% | -327 | |
0 |
| 15/03/23 | MANITOU GROUP | Achat | 1 000 E | 25.00 | 22.35 | -11.07% | -111 | |
0 |
| 15/03/23 | EKINOPS | Achat | 2 000 E | 8.94 | 8.85 | -1.42% | -28 | |
1 |
| 15/03/23 | JACQUET METALS | Achat | 1 000 E | 18.60 | 17.78 | -5.09% | -51 | |
0 |
| 15/03/23 | JACQUET METALS | Achat | 2 000 E | 19.28 | 17.78 | -8.30% | -166 | |
1 |
| 13/03/23 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 1 000 E | 0.79 | 0.80 | 0.95% | 10 | |
1 |
| 13/03/23 | EKINOPS | Achat | 2 000 E | 8.96 | 9.11 | 1.31% | 26 | |
1 |
| 06/03/23 | ESKER | Achat | 400 E | 149.00 | 148.50 | -0.54% | -2 | |
1 |
| 06/03/23 | EUROFINS SCIENTIFIC SE
|
Achat | 300 E | 56.16 | 62.10 | 10.37% | 31 | |
6 |
| 06/03/23 | EUROFINS SCIENTIFIC SE | Achat | 400 E | 84.70 | 62.10 | -26.86% | -107 | |
7 |
| 06/03/23 | EUROFINS SCIENTIFIC SE | Achat | 400 E | 93.17 | 62.12 | -33.49% | -134 | |
6 |
| 06/03/23 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 2 000 E | 0.82 | 0.86 | 4.56% | 91 | |
1 |
| 03/03/23 | MANITOU GROUP | Achat | 1 000 E | 26.85 | 25.30 | -6.50% | -65 | |
1 |
| 28/02/23 | JACQUET METALS | Achat | 1 000 E | 17.44 | 19.54 | 10.73% | 107 | |
1 |
| 21/02/23 | JACQUET METALS | Achat | 1 000 E | 18.02 | 19.00 | 4.11% | 41 | |
1 |
| 10/02/23 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 1 000 E | 1.01 | 0.80 | -21.02% | -210 | |
1 |
| 17/01/23 | ESKER | Achat | 400 E | 190.00 | 166.90 | -12.35% | -49 | |
5 |
| 13/01/23 | ESKER | Achat | 400 E | 199.20 | 165.90 | -16.90% | -68 | |
5 |
| 13/01/23 | TXCOM | Achat | 400 E | 8.55 | 8.90 | 3.89% | 16 | |
1 |
| 28/12/22 | MOULINVEST | Achat | 400 E | 49.50 | 33.40 | -32.69% | -131 | |
3 |
| 21/12/22 | POXEL | Achat | 400 E | 5.90 | 1.04 | -82.49% | -330 | |
7 |
| 21/12/22 | POXEL | Achat | 400 E | 6.25 | 1.04 | -83.48% | -334 | |
10 |
| 21/12/22 | POXEL | Achat | 400 E | 2.58 | 1.04 | -59.83% | -239 | |
5 |
| 21/12/22 | POXEL | Achat | 300 E | 6.74 | 1.03 | -84.83% | -254 | |
7 |
| 21/12/22 | POXEL | Achat | 300 E | 6.72 | 1.03 | -84.79% | -254 | |
5 |
| 21/12/22 | POXEL | Achat | 400 E | 5.81 | 1.03 | -82.39% | -330 | |
6 |
| 21/12/22 | POXEL | Achat | 300 E | 7.37 | 1.03 | -86.14% | -258 | |
7 |
| 21/12/22 | POXEL | Achat | 300 E | 7.20 | 1.03 | -85.81% | -257 | |
6 |
| 21/12/22 | POXEL | Achat | 300 E | 7.05 | 1.03 | -85.50% | -257 | |
8 |
| 21/12/22 | POXEL | Achat | 400 E | 6.07 | 1.03 | -83.15% | -333 | |
6 |
| 21/12/22 | POXEL | Achat | 300 E | 6.92 | 1.03 | -85.23% | -256 | |
6 |
| 21/12/22 | POXEL | Achat | 400 E | 1.54 | 1.03 | -33.28% | -133 | |
3 |
| 21/12/22 | POXEL | Achat | 400 E | 1.59 | 1.03 | -35.38% | -142 | |
2 |
| 19/09/22 | GENSIGHT BIOLOGICS SA | Achat | 200 E | 3.09 | 3.95 | 27.60% | 55 | |
7 |
| 19/09/22 | GENSIGHT BIOLOGICS SA | Achat | 300 E | 3.40 | 3.95 | 15.96% | 48 | |
6 |
| 19/09/22 | GENSIGHT BIOLOGICS SA | Achat | 300 E | 4.80 | 3.92 | -18.52% | -56 | |
9 |
| 19/09/22 | GENSIGHT BIOLOGICS SA | Achat | 300 E | 3.63 | 3.92 | 7.78% | 23 | |
8 |
| 07/09/22 | THERADIAG | Achat | 300 E | 2.64 | 1.50 | -43.34% | -130 | |
7 |
| 07/09/22 | THERADIAG | Achat | 300 E | 1.65 | 1.50 | -9.28% | -28 | |
22 |
| Enregistrements 301 à 350 sur 1162 | |||||||||



